MedPath

Efficacy Study on the Lipid-lowering Effect of Plant Sterols and Fish Oil

Not Applicable
Completed
Conditions
Mildly Elevated Cholesterol Levels
Healthy
Interventions
Dietary Supplement: Plant sterols and fish oil
Dietary Supplement: Placebo
Dietary Supplement: Plant sterols
Registration Number
NCT01313988
Lead Sponsor
Unilever R&D
Brief Summary

Plant sterols and fish fatty acids are known to affect the blood lipid profile. This randomized, double-blind, placebo-controlled, parallel efficacy study is designed to investigate the lipid-lowering effect after 4 weeks intervention with the recommended dose of plant sterols and different doses of fish fatty acids when combined in a spread format.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
332
Inclusion Criteria
  • Apparently healthy men and women
  • Age ≥ 25 and ≤ 75 years old
  • Body mass index (BMI) ≥ 18 and ≤ 30 kg/m2
  • Total cholesterol levels at screening ≥ 5.0 and ≤ 8.0 mmol/L
  • 10-year CVD risk equal or lower than 10% according to "SCORE"
  • Blood pressure, heart rate, hematological parameters, clinical chemical parameters within normal reference ranges
  • Informed consent and biobank consent signed
  • Willing to comply to study protocol during study
  • Agreeing to be informed about medically relevant personal test-results by a physician
  • Not smoking
  • Accessible veins on the forearm
  • Habitually consuming spreads
Exclusion Criteria
  • Pregnant or having the wish to become pregnant, or lactating
  • Use of prescribed medication which may interfere with study measurements
  • Use of antibiotics in the 3 months before screening or during the study
  • Use of any medically- or self-prescribed diet with the purpose to reduce weight
  • Intolerance for gluten or lactose
  • Reported food allergy
  • Having bleeding disorders
  • Recent blood donation
  • Excessive alcohol consumption
  • Strenuous exercise
  • Reported weight change ≥ 10 % of body weight or use of prescribed weight reduction drugs
  • Recent participation in another nutritional or medical trial
  • Participation in night shift work

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Dose 1Plant sterols and fish oilSpread that contains plant sterols and fish oil
Dose 2Plant sterols and fish oilSpread that contains plant sterols and fish oil
Dose 3Plant sterols and fish oilSpread that contains plant sterols and fish oil
PlaceboPlaceboPlacebo spread
ControlPlant sterolsSpread that contains plant sterols
Primary Outcome Measures
NameTimeMethod
Change in blood lipid profileAt baseline (after 4 weeks run-in period) and after 4 weeks intervention

Includes total cholesterol, LDL-cholesterol, HDL-cholesterol and triglycerides

Secondary Outcome Measures
NameTimeMethod
Change in EPA/DHA in red blood cellsAt baseline (after 4 weeks run-in period) and after 4 weeks intervention
Change in metabolomic parametersAt baseline (after 4 weeks run-in period) and after 4 weeks intervention

For exploratory purposes

Trial Locations

Locations (1)

KPL Good Food Practice AB

🇸🇪

Uppsala, Sweden

© Copyright 2025. All Rights Reserved by MedPath